首页 | 本学科首页   官方微博 | 高级检索  
     

Mifepristone in Combination with Misoprostol for the Termination of Pregnancy at 8-16 Weeks' Gestational Age: A Multicentre Randomized Controlled Trial
引用本文:Qiu-ju CHEN,Ju ZHANG,Zi-rong HUANG,Xiao-fang FAN,Hai-yun WANG,Hong ZHU,Shu-ping HOU,Yu-huan LIU,Qin-qin QIAO,Ping ZHANG,Yan LIU,Chun-mei QIAN,Yue-di TAN,Ai-hong LI,Catherine Meads,Wei-hong ZHANG,Li-nan CHENG. Mifepristone in Combination with Misoprostol for the Termination of Pregnancy at 8-16 Weeks' Gestational Age: A Multicentre Randomized Controlled Trial[J]. 生殖与避孕(英文版), 2013, 24(2): 101-113. DOI: 10.7669/j.issn.1001-7844.2013.02.0101
作者姓名:Qiu-ju CHEN  Ju ZHANG  Zi-rong HUANG  Xiao-fang FAN  Hai-yun WANG  Hong ZHU  Shu-ping HOU  Yu-huan LIU  Qin-qin QIAO  Ping ZHANG  Yan LIU  Chun-mei QIAN  Yue-di TAN  Ai-hong LI  Catherine Meads  Wei-hong ZHANG  Li-nan CHENG
作者单位:[1]Shanghai Institute of Planned Parenthood Research, Shanghai 200032, China [2]Shanghai Pharmaceutical (group) Company New Hualian Pharmaceutical Factory, Shanghai 201419, China [3]Obstertrics & Gynecology Hospital of Fudan University, Shanghai 200010, China [4]The Maternity and Child Hospital of Putuo District, Shanghai 200060, China [5]The First Maternity and Child Hospital of Tongii University, Shanghai 200040, China [6]Gongli Hospital of Pudong District, Shanghai 200135, China [7]Department of Gynecology & Obstetric, the Sixth Hospital Affiliated Shanghai Jiaotong University, Shanghai 200233, China [8]Shanghai Changhai Hospital, Shanghai 200433, China [9]The first Hospital of Shanghai, Shanghai 200080, China [10]Xinhua Hospital of Shanghai Jiaotong University, Shanghai 200092, China [11]Ruijin Hospital of Shanghai Jiaotong University, Shanghai 200025, China [12]The Tenth Hospital of Shanghai, Shanghai 200072, China [13]The Centre Hospital of Putuo District, Shanghai 200063, China [14]The Maternity & ChiM Hospital of Minhang District, Shanghai 201100, China [15]Barts and the London School of Medicine and Dentistry, Queen Mary University of London (for the EBM Connect Collaboration) [16]International Centre for Reproductive Health, Ghent University, Belgium; University Libre de Bruxelles, Perinatal Epidemiology and Reproductive Health Unit, School of Public Health, Brussels, Belgium
基金项目:This study was supported by the Science and Technology Commission of Shanghai Municipality (No. 09DZ 1905700) and the EBM-CONNECT Collaboration (Proposal No.: 101377; Grant Agreement No.: 247613) Acknowledgements We thank Shanghai Pharmaceutical (group) Company New Hualian Pharmaceutical Factory for freely providing the drugs ofmifepristone and misoprostol. The EBM-CONNECT (Evidence-Based Medicine Collaboration: Network for systematic reviews and guideline development research and dissemination) Collaboration (in alphabetical order by country): Mignini L, Centro Rosarino de Estudios Perinatales, Argentina; von Dadelszen P, Magee L, Sawchuck D, University of British Columbia, Canada; Gao ES, Shanghai Institute of Planned Parenthood Research, China; Mol BW, Oude Rengerink K, Academic Medical Centre, Netherlands; Zamora J, Ramony Cajal, Spain; Fox C, Daniels J, University of Birmingham; Khan KS, Thangaratinam S, Meads C, Barts and the London School of Medicine, Queen Mary University of London, United Kingdom.
摘    要:

关 键 词:米非司酮  随机对照试验  妊娠  多中心    药物流产  年龄  配伍
收稿时间:2012-11-19

Mifepristone in Combination with Misoprostol for the Termination of Pregnancy at 8-16 Weeks' Gestational Age: A Multicentre Randomized Controlled Trial
Qiu-ju CHEN,Ju ZHANG Company New Hualian Pharmaceutical Factory,Shanghai,China),Zi-rong HUANG,Xiao-fang FAN,Hai-yun WANG,Hong ZHU,Shu-ping HOU. Mifepristone in Combination with Misoprostol for the Termination of Pregnancy at 8-16 Weeks' Gestational Age: A Multicentre Randomized Controlled Trial[J]. Journal of Reproduction and Contraception, 2013, 24(2): 101-113. DOI: 10.7669/j.issn.1001-7844.2013.02.0101
Authors:Qiu-ju CHEN  Ju ZHANG Company New Hualian Pharmaceutical Factory  Shanghai  China)  Zi-rong HUANG  Xiao-fang FAN  Hai-yun WANG  Hong ZHU  Shu-ping HOU
Affiliation:Qiu-ju CHEN (Shanghai Institute of Planned Parenthood Research, Shanghai 200032, China); Ju ZHANG (Shanghai Pharmaceutical(group)Company New Hualian Pharmaceutical Factory, Shanghai 201419, China); Zi-rong HUANG (Obstertrics & Gynecology Hospital of Fudan University, Shanghai 200010, China); Xiao-fang FAN (The Maternity and Child Hospital of Putuo District, Shanghai 200060, China); Hai-yun WANG (The First Maternity and Child Hospital of Tongji University, Shanghai 200040, China); Hong ZHU (Gongli Hospital of Pudong District, Shanghai 200135, China); Shu-ping HOU(Department of Gynecology & Obstetric, the Sixth Hospital Affiliated Shanghai Jiaotong University, Shanghai 200233, China);
Abstract:
Keywords:medical abortion  8 16 weeks' gestation  randomized controlled trial (RCT)
本文献已被 维普 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号